본문 바로가기
  • Home

A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT)

  • CELLMED
  • Abbr : CellMed
  • 2023, 13(5), pp.20-20
  • DOI : 10.5667/CellMed.spc.020
  • Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
  • Research Area : Medicine and Pharmacy > General Medicine
  • Received : April 28, 2023
  • Accepted : April 28, 2023
  • Published : April 28, 2023

Young-ro Kim 1

1Jayeonjuui Pharmacy

Irregular Papers

ABSTRACT

Objective: A case report on the improvement of patients with hematologic malignancies by Ortho-Cellular Nutrition Therapy (OCNT). Methods: A 69-year-old Korean female diagnosed with Stage 4 ACUTE LYMPHOBLASTIC Leukemia (ALL) had a very low platelet count of 8000/μl. Results: The platelet count improved to its normal level after Ortho-Cellular Nutrition Therapy (OCNT). Conclusion: Ortho-Cellular Nutrition Therapy (OCNT) is effective in relieving the symptoms of acute lymphoblastic leukemia patients with thrombocytopenia.

Citation status

* References for papers published after 2022 are currently being built.